Showing 952 results

Filters Content type: News, Editors' picks, About HIV Topic: Side effects

The most common side effects of anti-HIV drugs are short term and are the result of the body getting used to a new drug. Long-term adverse effects and toxicities are less common.

New & experimental HIV treatments

HIV: Could Another Two-Drug Regimen Be on the Horizon?

Editor's pick
Medscape (requires free registration)
21 July 2021
Neurological & cognitive problems

New predictors for peripheral neuropathy found in study of people living with HIV

News
6 July 2021
Treatment outcomes & life expectancy

Spanish studies highlight scale of late presentation and its consequences for treatment

News
24 June 2021
Sexual health

Delayed HIV treatment initiation and protease inhibitors associated with erectile dysfunction in men living with HIV

News
31 May 2021
Health problems & ageing

Nausea, vomiting and HIV

About HIV
May 2021
Health problems & ageing

Diarrhoea and HIV

About HIV
May 2021
Pregnancy and vertical transmission

Antiretrovirals for HIV Don’t Raise Birth Defect Risk

Editor's pick
POZ
27 March 2021
Bone & joint problems

Alendronate can prevent bone loss in people starting HIV treatment

News
9 March 2021
Side effects

Meta-analysis finds no real difference in safety and effectiveness between tenofovir formulations

News
5 January 2021
Weight gain & lipodystrophy

Genetics may contribute to weight gain after switching from efavirenz to an integrase inhibitor

News
2 October 2020
Diabetes

No increased risk of diabetes with integrase inhibitors in people starting HIV treatment

News
11 September 2020
Treatment guidelines

1.3m switched to new ARV, but weight gain is a concern

Editor's pick
Spotlight
25 August 2020
Pharmaceutical industry

U.K. marketing police slam Gilead for claiming Biktarvy tolerability beats GSK rival

Editor's pick
FiercePharma
15 July 2020
Neurological & cognitive problems

Neuropathy and Neuropathic Pain Still on Rise in HIV+, But No Clear Links to ART

Editor's pick
NATAP
10 July 2020
Bone & joint problems

Depo Provera may worsen tenofovir-related bone loss in young women

News
9 July 2020
New & experimental HIV treatments

Islatravir plus doravirine maintains viral suppression for a year

News
5 July 2020
Clinical trials

Black people and women are under-represented in anti-HIV drug studies

News
25 May 2020
Cardiovascular disease

People switching from TDF to TAF experience rising cholesterol levels

News
7 May 2020
Side effects

Can This Medicine From a Rainforest Plant Stop Chronic Diarrhea in Folks With HIV?

Editor's pick
TheBody
1 May 2020
PrEP science

Older age and baseline kidney function are the key risk factors for renal dysfunction while taking HIV PrEP

News
23 March 2020
Weight gain & lipodystrophy

Weight gain after starting HIV treatment may have genetic influences

News
18 March 2020
PrEP policies & guidelines

Far fewer people would get PrEP in the US if generic TDF/FTC is replaced with Descovy (TAF/FTC), cost-effectiveness study finds

News
9 March 2020
PrEP science

Uptick in Statin Use After Descovy in HIV PrEP

Editor's pick
Medscape (requires free registration)
9 March 2020
Treatment guidelines

South Africa: Health Department’s dolutegravir plans hit stumbling block

Editor's pick
MedicalBrief
2 March 2020